Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Waters Corp
NYSE:WAT
|
US |
Mind Medicine (MindMed) Inc
Operating Income
Mind Medicine (MindMed) Inc
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Operating Income
-$151.2m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-57%
|
CAGR 10-Years
-123%
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Operating Income
$2.2B
|
CAGR 3-Years
16%
|
CAGR 5-Years
11%
|
CAGR 10-Years
0%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Operating Income
-CA$52.8m
|
CAGR 3-Years
57%
|
CAGR 5-Years
42%
|
CAGR 10-Years
-9%
|
|
|
Sundial Growers Inc
NASDAQ:SNDL
|
Operating Income
-CA$4.4m
|
CAGR 3-Years
56%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Operating Income
-$14.6m
|
CAGR 3-Years
48%
|
CAGR 5-Years
39%
|
CAGR 10-Years
-23%
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Operating Income
CA$5.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Mind Medicine (MindMed) Inc
Glance View
Mind Medicine (MindMed), Inc. operates as a neuro-pharmaceutical company that discovers, develops and deploys psychedelic medicines to improve health, promote wellness and alleviate suffering. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2015-05-04. The firm focuses on discovering, developing and deploying psychedelic-inspired medicines and therapies to address addiction and mental illness. The firm's commercial drug development programs includes lysergic acid diethylamide (LSD) experiential therapy, 18-methoxycoronaridine (18-MC) opioid withdrawal, LSD microdosing, methylenedioxymethamphetamine (MDMA), and dimethyltryptamine (DMT). The firm's subsidiaries include Mind Medicine, Inc., HealthMode, Inc., MindMed Pty Ltd. and MindMed GmbH.
See Also
What is Mind Medicine (MindMed) Inc's Operating Income?
Operating Income
-151.2m
USD
Based on the financial report for Sep 30, 2025, Mind Medicine (MindMed) Inc's Operating Income amounts to -151.2m USD.
What is Mind Medicine (MindMed) Inc's Operating Income growth rate?
Operating Income CAGR 10Y
-123%
Over the last year, the Operating Income growth was -61%. The average annual Operating Income growth rates for Mind Medicine (MindMed) Inc have been -29% over the past three years , -57% over the past five years , and -123% over the past ten years .